Location History:
- Como, IT (1977)
- Fino Mornasco, IT (1986)
- Cassina Rizzardi, IT (1990)
Company Filing History:
Years Active: 1977-1990
Title: Vittorio Arioli: Innovator in Antibiotic Development
Introduction
Vittorio Arioli is a notable inventor based in Cassina Rizzardi, Italy. He has made significant contributions to the field of antibiotics, holding a total of 4 patents. His work focuses on developing new antibiotic substances that can combat infectious diseases.
Latest Patents
Arioli's latest patents include the Antibiotic A 40926 complex and its pure factors, which are designed to treat infections caused by susceptible microorganisms. This invention involves a new antibiotic substance, antibiotic A 40926 complex, and its factors, including antibiotic A 40926 factor A, factor B, factor B.sub.0, factor PA, and factor PB. The process for producing these substances involves culturing the new strain Actinomadura sp. ATCC 39727 or its variants. These glycopeptidic substances belong to the vancomycin class of antibiotics and have a binding capacity to Acyl-D-Alanyl-D-Alanine. Another significant patent is Antibiotic SB 22484, which also focuses on a new antibiotic substance produced by culturing Streptomyces sp. NRRL 15496 or its variants. This antibiotic is intended for the treatment of infectious diseases involving susceptible microorganisms.
Career Highlights
Arioli is currently associated with Gruppo Lepetit S.p.a., where he continues to innovate in the field of antibiotic research. His work has been instrumental in advancing the development of new antibiotic therapies.
Collaborations
Some of his notable coworkers include Enrico Selva and Grazia Beretta, who have collaborated with him on various projects related to antibiotic development.
Conclusion
Vittorio Arioli's contributions to antibiotic research highlight his commitment to addressing infectious diseases through innovative solutions. His patents reflect a significant advancement in the field, showcasing his expertise and dedication to improving healthcare outcomes.